From: Acromegaly and thyroid cancer: analysis of evolution in a series of patients
Stage | |
I | 19/24 (79%) |
II | 4/24 (17%) |
IVb | 1/24 (4%) |
Initial RR | |
Low | 21/24 (87%) |
Intermediate | 2/24 (9%) |
High | 1/24 (4%) |
Initial response | |
Excellent | 12/23 (52%) |
Indeterminate | 7/23 (31%) |
Biochemical incomplete | 3/23 (13%) |
Structural incomplete | 1/23 (4%) |
RFU | |
No evidence of disease | 19/23 (83%) |
Indeterminate | 2/23 (9%) |
Biochemical incomplete | 1/23 (4%) |
Structural incomplete | 1/23 (4%) |